Timber Creek Capital Management’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-100
Closed -$3K 137
2022
Q3
$3K Hold
100
﹤0.01% 132
2022
Q2
$3K Hold
100
﹤0.01% 125
2022
Q1
$4K Hold
100
﹤0.01% 121
2021
Q4
$4K Hold
100
﹤0.01% 111
2021
Q3
$4K Hold
100
﹤0.01% 117
2021
Q2
$4K Hold
100
﹤0.01% 121
2021
Q1
$3K Hold
100
﹤0.01% 119
2020
Q4
$3K Hold
100
﹤0.01% 118
2020
Q3
$3K Hold
100
﹤0.01% 115
2020
Q2
$3K Hold
100
﹤0.01% 110
2020
Q1
$3K Hold
100
﹤0.01% 118
2019
Q4
$4K Hold
100
﹤0.01% 122
2019
Q3
$4K Hold
100
﹤0.01% 119
2019
Q2
$4K Hold
100
﹤0.01% 121
2019
Q1
$3K Hold
100
﹤0.01% 118
2018
Q4
$3K Buy
+100
New +$3.63K ﹤0.01% 118

Other funds holding BSX

Timber Creek Capital Management's BSX Position: Q4 2022 in Review

Timber Creek Capital Management sold out of Boston Scientific (BSX) in Q4 2022, closing a stake of 100 shares — an estimated $3K sold.

Timber Creek Capital Management first reported a position in BSX in Q4 2018 and held it in 16 quarters. The position peaked at $4K in Q1 2022. 928 funds tracked by Wall St. Rank hold BSX as of Q4 2022.

  • Timber Creek Capital Management reported no remaining Boston Scientific position as of Q4 2022 after selling out during the quarter.
  • Timber Creek Capital Management sold 100 Boston Scientific shares in Q4 2022, an estimated $3K.
  • Timber Creek Capital Management first reported a position in Boston Scientific in Q4 2018 and held it in 16 quarters.
  • Timber Creek Capital Management's Boston Scientific position peaked at $4K in Q1 2022.
  • 928 funds tracked by Wall St. Rank held Boston Scientific as of Q4 2022.

Based on Timber Creek Capital Management's 13F filing for Q4 2022, filed 23 Jan 2023.